...
【24h】

Spectrophotometric determination of metronidazole and tinidazole in pharmaceutical preparations.

机译:分光光度法测定药物制剂中的甲硝唑和替硝唑

获取原文
获取原文并翻译 | 示例
           

摘要

Sensitive and simple spectrophotometric methods for the determination of metronidazole (MNZ) and tinidazole (TNZ) in either pure form or in its pharmaceutical formulations are described. The first method is based on the interaction of 3-methylbenzothiazolin-2-one hydrazone (MBTH) with MNZ/TNZ (reduced drug) in presence of copper sulphate and pyridine in acidic medium. The resulting yellowish orange products have lambda(max) of 500 and 490 nm, respectively, for MNZ and TNZ and are stable for about 4 h. The second method describes the reaction between reduced diazotised drugs with N-(1-naphthyl)ethylenediamine dihydrochloride (NEDA) in neutral medium to yield pink products which have lambda(max) of 520 and 505 nm, respectively, for MNZ and TNZ, respectively. The products are stable for more than 24 h. Common excipients used as additives in pharmaceutical preparations do not interfere in the proposed method. Both the methods are highly reproducible and have been applied to a wide variety of pharmaceutical preparations and the results compare favourably with those of official methods.
机译:描述了测定纯形式或其药物制剂中甲硝唑(MNZ)和替硝唑(TNZ)的灵敏,简单的分光光度法。第一种方法是基于在酸性介质中存在硫酸铜和吡啶的情况下,3-甲基苯并噻唑啉-2-酮(MBTH)与MNZ / TNZ(还原药物)的相互作用。对于MNZ和TNZ,所得的淡橙色产物的lambda(max)分别为500和490 nm,并且稳定约4 h。第二种方法描述了还原的重氮化药物与N-(1-萘基)乙二胺二盐酸盐(NEDA)在中性介质中的反应,产生的粉红色产品分别对MNZ和TNZ的λ(最大)分别为520和505 nm。 。产品稳定超过24小时。在药物制剂中用作添加剂的常见赋形剂不会干扰建议的方法。两种方法均具有高度可重复性,并且已应用于多种药物制剂,其结果与官方方法相比具有优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号